Logo
Login
$PGEN
$6.23 +$0.08 (1.3%) After hours

Company Executives

$PGEN Management Team

Mr. Phil Tennant

Chief Commercial Officer

Age 55
Compensation $518.3K USD
Sex Male

Mr. Rutul Shah

Chief Operating Officer

Age 44
Compensation $1.408M USD
Sex Male

Mr. Randal Kirk

Executive Chairman of the Board

Age 71
Compensation $600.0K USD
Sex Male

Dr. Helen Sabzevari

President

Chief Executive Officer

Director

President of PGEN Therapeutics

Inc.

Age 63
Compensation $5.432M USD
Sex Female

Mr. Harry Thomasian

Chief Financial Officer

Age 63
Compensation $1.402M USD
Sex Male

Mr. Donald Lehr

Chief Legal Officer

Corporate Secretary

Age 50
Compensation $1.352M USD
Sex Male

Board of Directors

From the proxy statement filed Apr 30, 2026
Directors
9
serving now
Independent
1 of 1
stated in the proxy; 8 not stated
Average tenure
12.0 years
from year joined
CEO also chairs the board
No
Randal Kirk
Director Age On board Independent Committees Other public boards 2025 pay Source
Randal Kirk
Board chair
 72 2008
18 years
 Not stated None stated None stated $600,000
Nancy Howell Agee
73 2024
2 years
 Not stated None stated None stated $306,500
Cesar Alvarez
78 2008
18 years
 Not stated
Nominating and Governance Committee · Chair
Watsco, Inc. $312,500
Steven Frank
66 2008
18 years
 Not stated None stated BioCryst Pharmaceuticals, Inc. $300,000
Vinita Gupta
58 2017
9 years
 Not stated
Audit Committee Nominating and Governance Committee
None stated $313,000
Fred Hassan
80 2016
10 years
 Not stated None stated None stated $313,000
Jeffrey Kindler
70 2011
15 years
 Not stated
Audit Committee · Chair
None stated $319,000
Helen Sabzevari
CEO
 64 2020
6 years
 Not stated None stated None stated Paid as CEO
James Turley
70 2014
12 years
 Independent
Compensation Committee · Chair
Citigroup Inc. $312,500

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

No related-party transactions disclosed

The proxy filed Apr 30, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans